HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James Harrison Selected Research

Therapeutics

4/2022Atrial CARdiac Magnetic resonance imaging in patients with embolic stroke of unknown source without documented Atrial Fibrillation (CARM-AF): Study design and clinical protocol.
1/2021Safety and efficacy of catheter directed thrombolysis (CDT) in elderly with pulmonary embolism (PE).
12/2020Economic evaluation of nivolumab combined with ipilimumab in the first-line treatment of advanced melanoma in Japan.
10/2020Clinical Significance of Manuka and Medical-Grade Honey for Antibiotic-Resistant Infections: A Systematic Review.
5/2017Evaluation of the Antimicrobial Activity of Cationic Polymers against Mycobacteria: Toward Antitubercular Macromolecules.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James Harrison Research Topics

Disease

9Atherosclerosis
11/2020 - 07/2012
8Infections
01/2022 - 05/2017
6Tuberculosis (Tuberculoses)
11/2021 - 01/2015
5Atrial Fibrillation
04/2022 - 07/2012
5Cicatrix (Scar)
12/2019 - 02/2014
3Infarction (Infarctions)
01/2021 - 03/2013
3Pain (Aches)
01/2019 - 01/2004
3Atherosclerotic Plaque (Atheroma)
01/2019 - 08/2013
3Neoplasms (Cancer)
01/2016 - 05/2011
2Abdominal Aortic Aneurysm
01/2019 - 11/2004
1Ischemic Stroke
04/2022
1False Aneurysm (Pseudoaneurysm)
01/2022
1Multiple Sclerosis
01/2022
1Cystic Fibrosis (Mucoviscidosis)
01/2022
1Pulmonary Embolism
01/2021
1Persistent Infection
01/2021
1Myocardial Infarction
01/2021
1Ventricular Tachycardia
01/2021
1Hemorrhage
01/2021
1Granuloma
01/2021
1Hypoxia (Hypoxemia)
01/2021
1Melanoma (Melanoma, Malignant)
12/2020
1Fibrosis (Cirrhosis)
10/2019
1Aneurysm (Aneurysms)
01/2019
1Aortic Aneurysm (Aneurysm, Aortic)
01/2019
1Aortic Rupture
01/2019
1Fatigue
01/2019
1Inflammation (Inflammations)
01/2019
1Rupture
01/2019
1Hematologic Neoplasms (Hematological Malignancy)
01/2019
1Slipped Capital Femoral Epiphyses
06/2017
1Hemolysis
05/2017
1Cardiac Arrhythmias (Arrythmia)
04/2017
1Death (Near-Death Experience)
01/2016
1Communicable Diseases (Infectious Diseases)
01/2016
1Vascular Diseases (Vascular Disease)
12/2014
1Mitochondrial Diseases (Mitochondrial Disease)
08/2013
1Hyperlipidemias (Hyperlipidemia)
08/2013
1Ovarian Neoplasms (Ovarian Cancer)
05/2011
1Chronic Pain
09/2007
1Ataxia (Dyssynergia)
09/2007
1Anxiety Disorders (Anxiety Disorder)
10/2005
1Alcohol-Related Disorders
10/2005
1Mood Disorders (Mood Disorder)
10/2005

Drug/Important Bio-Agent (IBA)

6GadoliniumIBA
01/2021 - 10/2015
5Pharmaceutical PreparationsIBA
01/2022 - 10/2005
4Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 01/2016
3CholesterolIBA
11/2020 - 01/2018
2Phosphotransferases (Kinase)IBA
01/2021 - 01/2019
2LDL Receptors (LDL Receptor)IBA
11/2019 - 01/2019
2Apolipoproteins E (ApoE)IBA
01/2019 - 08/2013
2EnzymesIBA
01/2019 - 01/2016
2ApolipoproteinsIBA
02/2015 - 08/2013
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2014 - 08/2013
2Mitochondrial DNA (mtDNA)IBA
03/2014 - 08/2013
1Glatiramer Acetate (Copaxone)FDA Link
01/2022
1Tobramycin (Nebcin)FDA LinkGeneric
01/2022
1Peptides (Polypeptides)IBA
01/2022
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2021
1NivolumabIBA
12/2020
1IpilimumabIBA
12/2020
1Triglycerides (Triacylglycerol)IBA
11/2020
1relebactamIBA
01/2020
1Amoxicillin (Wymox)FDA LinkGeneric
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2019
1Autophagy-Related Protein 5IBA
01/2019
1AntibodiesIBA
01/2019
1Immunoglobulin G (IgG)IBA
01/2019
1Immunoglobulin M (IgM)IBA
01/2019
1Inositol (Myoinositol)IBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2019
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2019
1Glycerophospholipids (Phosphoglycerides)IBA
01/2019
1InflammasomesIBA
01/2019
1polycationsIBA
05/2017
1MethacrylatesIBA
05/2017
1Peptidoglycan (Murein)IBA
03/2015
1Proteins (Proteins, Gene)FDA Link
02/2015
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
02/2015
1LipidsIBA
01/2015
1CarbohydratesIBA
01/2015
1Transforming Growth Factors (Transforming Growth Factor)IBA
12/2014
1Cyclin-Dependent Kinases (cdk Proteins)IBA
12/2014
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
03/2013
1B-Cell Activation Factor ReceptorIBA
07/2012
1B-Cell Activating FactorIBA
07/2012
1AntigensIBA
05/2011
1WAY 132983IBA
09/2007
1bicyclo(2.2.1)hepteneIBA
09/2007
1Muscarinic AgonistsIBA
09/2007
1Irritants (Vesicants)IBA
09/2007

Therapy/Procedure

5Therapeutics
04/2022 - 05/2017
4Catheter Ablation
10/2019 - 07/2012
3Catheters
01/2022 - 12/2019
1Massage (Zone Therapy)
01/2019
1Osteotomy
06/2017
1Palliative Care (Palliative Therapy)
01/2016
1Aftercare (After-Treatment)
03/2013
1Analgesia
09/2007